Tuesday, October 20, 2026, 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
April 2019—Abbott announced that Regional Medical Laboratory, of Tulsa, Okla., will use Abbott’s Alinity ci-series. RML, part of the Ascension network, performs diagnostics testing for more than 2.4 million patients through hospital systems in Texas, Wisconsin, Oklahoma, Kansas, and Tennessee.
April 2019—Ortho Clinical Diagnostics, in collaboration with Beijing Leadman Biochemistry, launched four MicroTip partnership assays in China. The assays, for renal, liver, and cardiac testing, include cystatin C, α-hydroxybutyrate dehydrogenase, homocysteine, and total bile acid.
April 2019—The U.S. Food and Drug Administration is issuing a proposed order to exempt certain class II flow cytometry instruments from premarket notification (510[k]) requirements, subject to limitations and conditions.
April 2019—Qiagen and Tecan Group announced a collaboration to improve the processing of Qiagen’s QuantiFeron-TB Gold Plus diagnostic test. The companies are working together to optimize a solution that standardizes and automates the manual steps in liquid handling for the aliquoting of samples.
April 2019—LGC Maine Standards has added Cerebrospinal Fluid Total Protein to its Validate Body Fluids kit for laboratory-developed test validation, documentation of linearity, calibration verification, and verification of the reportable range.
April 2019—PMT Scientific, a company that designs morgue, pathology, histology, and vivarium medical equipment, is now operating in Redford, Mich. PMT Scientific focuses on providing custom grossing stations along with a complete array of pathology equipment. Its grossing stations incorporate height-adjustable actuators, high-color-rendering lighting, and durable and easy-to-maintain plumbing fixtures, and can come equipped with air quality monitoring devices.
April 2019—Abbott announced it has received the CE mark for its Alinity m automated molecular diagnostics system and assays. Alinity m features ReadiFlex technology, the company’s proprietary technology for true random access, a universal sample rack, and a time to first result of less than 115 minutes. The system can provide 300 results in about eight hours and can have up to 20 assays onboard at one time.
April 2019—EKF Diagnostics has signed a private label distribution agreement with McKesson Medical-Surgical for the company’s hand-held, reagent-free hemoglobin analyzer, the DiaSpect. The DiaSpect will be sold by McKesson under its own branded line as the McKesson Consult Hb analyzer.
March 2019—Sarstedt has released its next generation of vacuum filtration products. Options include bottle top filters, receiver bottles, and assembled units available in 250 mL, 500 mL, and 1,000 mL. The filters contain wide, 90-mm diameter polyethersulfone membranes with 0.2 µm and 0.45 µm pore sizes; 500 mL filters are also available with a 0.1 µm pore size for mycoplasma removal. The bottle tops are one-piece construction to prevent leakage above the neck and reduce overall height.
March 2019—Fluidigm introduced its Maxpar Human Immune Monitoring Panel Kit for comprehensive immune cell profiling in cancer and immune-mediated diseases. The immune monitoring kit contains 29 metal-labeled antibodies and reagents designed for deep immune profiling of human peripheral blood mononuclear cells in one tube.
